A Survey of the Collection, Provision, and Application of Drug Safety Information at Hospitals

DOI
  • Masuyama Maki
    Office of Safety I, Pharmaceuticals and Medical Devices Agency Yamagata University Graduate School of Medical Science
  • Hasegawa Hirokazu
    Office of Safety I, Pharmaceuticals and Medical Devices Agency
  • Ikeda Mie
    Office of Safety I, Pharmaceuticals and Medical Devices Agency
  • Mori Kazuhiko
    Office of Safety I, Pharmaceuticals and Medical Devices Agency
  • Yoshino Keiko
    Department of Pharmacy, National Hospital Organization National Tokyo Medical Center
  • Ara Yoshiaki
    Department of Pharmacy, National Hospital Organization National Tokyo Medical Center
  • Miyashita Hisanori
    Department of Pharmacy, National Hospital Organization National Tokyo Medical Center
  • Ide Yasuo
    Department of Pharmacy, National Hospital Organization National Tokyo Medical Center
  • Suzuki Yoshihiko
    Department of Pharmacy, National Hospital Organization National Tokyo Medical Center
  • Hayashi Masahiro
    Department of Pharmacy, Toranomon Hospital
  • Matsuda Tsutomu
    Yamagata University Graduate School of Medical Science

Bibliographic Information

Other Title
  • 病院における医薬品の安全性情報の入手・伝達・活用に関する調査

Search this article

Description

Objective: We conducted a questionnaire survey to comprehend the situation regarding the collection, provision, and utilization of drug safety information at hospitals.  In addition, we asked pharmaceutical companies how they select medical institutions to provide drug safety information.  We also investigated the current situation of information provision to Tokyo Medial Center by pharmaceutical companies.<br>Method: A questionnaire was mailed to all hospitals in Japan.  The survey was conducted between January 13 and February 10, 2011.  Moreover, we asked thirteen pharmaceutical companies by telephone and e-mail about the implementation status of the provision of information and performed a survey at Tokyo Medical Center on the current situation of information provision by pharmaceutical companies regarding revisions to precaution sections in package inserts.<br>Results: The results of the questionnaire survey (response rate: 41.2%) showed that the major information sources for hospitals were medical representatives (77.8%), Drug Safety Update (50.3%) and direct mails (49.3%).  Furthermore, in the case of drugs prescribed exclusively for extramural dispensing, fewer hospitals responded that medical representatives of the pharmaceutical companies provided drug safety information and more hospitals responded that they did not obtain any drug safety information at all, compared with drugs listed in the hospital formularies.<br>Conclusion: To minimize the risks of drugs, healthcare professionals must collect a wide range of drug safety information and must utilize this information in their medical practice.  Therefore, it is important that pharmaceutical companies and regulatory authorities make an effort to provide suitable information dissemination to medical institutions.  Furthermore, medical institutions must also strengthen their systems for collecting drug safety information and providing such information to healthcare professionals.

Journal

Keywords

Details 詳細情報について

Report a problem

Back to top